SLCO1B1 and hepatocellular carcinoma: Moreover, this protein was correctly targeted at the plasma membrane of hepatoma cells, resulting in enhanced selective sensitivity to antitumor OATP1B1 substrates, such as paclitaxel and cisplatin-bile acid conjugates (Bamet-R2 and Bamet-UD2).